BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 35587857)

  • 21. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
    Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
    Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting tumor-associated macrophages in the tumor microenvironment.
    Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
    Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Single-Cell Level Perspective of the Tumor Microenvironment and Its Remodeling by CAR-T Cells.
    Gao S; Sugimura R
    Cancer Treat Res; 2022; 183():275-285. PubMed ID: 35551664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering the Intestinal Lymphatic Transport of Oral Nanoparticles to Educate Macrophages for Cancer Combined Immunotherapy.
    Xu L; Weng S; Li S; Wang K; Shen Y; Xu Y; Tang C; Yin C
    ACS Nano; 2023 Jun; 17(12):11817-11837. PubMed ID: 37318192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-derived exosomes in the regulation of macrophage polarization.
    Baig MS; Roy A; Rajpoot S; Liu D; Savai R; Banerjee S; Kawada M; Faisal SM; Saluja R; Saqib U; Ohishi T; Wary KK
    Inflamm Res; 2020 May; 69(5):435-451. PubMed ID: 32162012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and polarization regulation of macrophages in the tumor microenvironment.
    Wang J; Mi S; Ding M; Li X; Yuan S
    Cancer Lett; 2022 Sep; 543():215766. PubMed ID: 35690285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro evaluation of inhibitory effect of nuclear factor-kappaB activity by small interfering RNA on pro-tumor characteristics of M2-like macrophages.
    Kono Y; Kawakami S; Higuchi Y; Yamashita F; Hashida M
    Biol Pharm Bull; 2014; 37(1):137-44. PubMed ID: 24141263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization.
    Shi L; Gu H
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophages in tumor microenvironments and the progression of tumors.
    Hao NB; Lü MH; Fan YH; Cao YL; Zhang ZR; Yang SM
    Clin Dev Immunol; 2012; 2012():948098. PubMed ID: 22778768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic reprogramming of macrophages during infections and cancer.
    Wang S; Liu R; Yu Q; Dong L; Bi Y; Liu G
    Cancer Lett; 2019 Jun; 452():14-22. PubMed ID: 30905817
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Xu YW; Xing RX; Zhang WH; Li L; Wu Y; Hu J; Wang C; Luo QL; Shen JL; Chen X
    World J Gastroenterol; 2019 Dec; 25(45):6634-6652. PubMed ID: 31832003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-associated macrophage polarization in the inflammatory tumor microenvironment.
    Zou Z; Lin H; Li M; Lin B
    Front Oncol; 2023; 13():1103149. PubMed ID: 36816959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-23 and the Tumor Microenvironment.
    Subhadarshani S; Yusuf N; Elmets CA
    Adv Exp Med Biol; 2021; 1290():89-98. PubMed ID: 33559857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma.
    Anand N; Peh KH; Kolesar JM
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation and gene expression profile of tumor-associated macrophages.
    Schmieder A; Michel J; Schönhaar K; Goerdt S; Schledzewski K
    Semin Cancer Biol; 2012 Aug; 22(4):289-97. PubMed ID: 22349514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dental Follicle Stem Cells Ameliorate Lipopolysaccharide-Induced Inflammation by Secreting TGF-β3 and TSP-1 to Elicit Macrophage M2 Polarization.
    Chen X; Yang B; Tian J; Hong H; Du Y; Li K; Li X; Wang N; Yu X; Wei X
    Cell Physiol Biochem; 2018; 51(5):2290-2308. PubMed ID: 30537736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapy.
    Fendl B; Berghoff AS; Preusser M; Maier B
    ESMO Open; 2023 Feb; 8(1):100776. PubMed ID: 36731326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 39. Biological effects of IL-21 on immune cells and its potential for cancer treatment.
    Ma M; Xie Y; Liu J; Wu L; Liu Y; Qin X
    Int Immunopharmacol; 2024 Jan; 126():111154. PubMed ID: 37977064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HAI-1 is an independent predictor of lung cancer mortality and is required for M1 macrophage polarization.
    Borowicz S; Principe DR; Dorman MJ; McHenry AJ; Sondarva G; Kumar S; Ananthanarayanan V; Simms PE; Hess A; Rana A
    PLoS One; 2021; 16(6):e0252197. PubMed ID: 34185790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.